Cover Image
市場調查報告書

Digna Biotech, S.L.- 產品平台分析

Digna Biotech, S.L. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 204911
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
Digna Biotech, S.L.- 產品平台分析 Digna Biotech, S.L. - Product Pipeline Review - 2016
出版日期: 2016年02月29日 內容資訊: 英文 38 Pages
簡介

Digna Biotech, S.L.是總公司設立於西班牙的生物科技企業,正在開發硬皮症,腎臟移植及肝臟手術,急性間歇性紫質症,C型肝炎感染疾病等治療藥。

本報告提供Digna Biotech, S.L.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Digna Biotech, S.L. 的基本資料

  • Digna Biotech, S.L. 概要
  • 主要資訊
  • 企業資料

Digna Biotech, S.L. :R&D概要

  • 主要的治療範圍

Digna Biotech, S.L. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Digna Biotech, S.L. :開發中產品概況

  • 臨床階段的開發中產品
    • 第Ⅱ期的產品/聯合治療模式
    • 第Ⅰ期的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Digna Biotech, S.L. :藥物簡介

  • Cardiotrophin-1
  • disitertide
  • DB-017
  • DB-02901
  • DB-036
  • DB-039
  • DB-055
  • oncostatin M
  • DB-027

Digna Biotech, S.L. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Digna Biotech, S.L. :最近的開發平台資訊

Digna Biotech, S.L. :暫停開發中的計劃

Digna Biotech, S.L. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07968CDB

Summary

Global Markets Direct's, 'Digna Biotech, S.L. - Product Pipeline Review - 2016', provides an overview of the Digna Biotech, S.L.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Digna Biotech, S.L., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Digna Biotech, S.L.
  • The report provides overview of Digna Biotech, S.L. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Digna Biotech, S.L.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Digna Biotech, S.L.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Digna Biotech, S.L.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Digna Biotech, S.L.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Digna Biotech, S.L.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Digna Biotech, S.L. Snapshot
    • Digna Biotech, S.L. Overview
    • Key Information
    • Key Facts
  • Digna Biotech, S.L. - Research and Development Overview
    • Key Therapeutic Areas
  • Digna Biotech, S.L. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Digna Biotech, S.L. - Pipeline Products Glance
    • Digna Biotech, S.L. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Digna Biotech, S.L. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Digna Biotech, S.L. - Drug Profiles
    • Cardiotrophin-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • disitertide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Interferon Alfa-5
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DB-017
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DB-02901
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DB-036
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DB-039
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DB-055
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • oncostatin M
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DB-027
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Digna Biotech, S.L. - Pipeline Analysis
    • Digna Biotech, S.L. - Pipeline Products by Target
    • Digna Biotech, S.L. - Pipeline Products by Route of Administration
    • Digna Biotech, S.L. - Pipeline Products by Molecule Type
    • Digna Biotech, S.L. - Pipeline Products by Mechanism of Action
  • Digna Biotech, S.L. - Recent Pipeline Updates
  • Digna Biotech, S.L. - Dormant Projects
  • Digna Biotech, S.L. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Digna Biotech, S.L., Key Information
  • Digna Biotech, S.L., Key Facts
  • Digna Biotech, S.L. - Pipeline by Indication, 2016
  • Digna Biotech, S.L. - Pipeline by Stage of Development, 2016
  • Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016
  • Digna Biotech, S.L. - Partnered Products in Pipeline, 2016
  • Digna Biotech, S.L. - Partnered Products/ Combination Treatment Modalities, 2016
  • Digna Biotech, S.L. - Phase II, 2016
  • Digna Biotech, S.L. - Phase I, 2016
  • Digna Biotech, S.L. - Preclinical, 2016
  • Digna Biotech, S.L. - Discovery, 2016
  • Digna Biotech, S.L. - Pipeline by Target, 2016
  • Digna Biotech, S.L. - Pipeline by Route of Administration, 2016
  • Digna Biotech, S.L. - Pipeline by Molecule Type, 2016
  • Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016
  • Digna Biotech, S.L. - Recent Pipeline Updates, 2016
  • Digna Biotech, S.L. - Dormant Developmental Projects,2016
  • Digna Biotech, S.L., Other Locations
  • Digna Biotech, S.L., Subsidiaries

List of Figures

  • Digna Biotech, S.L. - Pipeline by Top 10 Indication, 2016
  • Digna Biotech, S.L. - Pipeline by Stage of Development, 2016
  • Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016
  • Digna Biotech, S.L. - Pipeline by Target, 2016
  • Digna Biotech, S.L. - Pipeline by Route of Administration, 2016
  • Digna Biotech, S.L. - Pipeline by Molecule Type, 2016
  • Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016
Back to Top